chempharm limited Company Information
Company Number
02884816
Website
chempharmindia.comRegistered Address
85 church vale, west bromwich, B71 4DH
Industry
Other personal service activities n.e.c.
Other human health activities
Telephone
01215887678
Next Accounts Due
June 2025
Group Structure
View All
Shareholders
pharmacylocal ltd 100%
chempharm limited Estimated Valuation
Pomanda estimates the enterprise value of CHEMPHARM LIMITED at £308.3k based on a Turnover of £619.6k and 0.5x industry multiple (adjusted for size and gross margin).
chempharm limited Estimated Valuation
Pomanda estimates the enterprise value of CHEMPHARM LIMITED at £260k based on an EBITDA of £58.8k and a 4.42x industry multiple (adjusted for size and gross margin).
chempharm limited Estimated Valuation
Pomanda estimates the enterprise value of CHEMPHARM LIMITED at £677k based on Net Assets of £294.4k and 2.3x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Chempharm Limited Overview
Chempharm Limited is a live company located in west bromwich, B71 4DH with a Companies House number of 02884816. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in January 1994, it's largest shareholder is pharmacylocal ltd with a 100% stake. Chempharm Limited is a mature, small sized company, Pomanda has estimated its turnover at £619.6k with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Chempharm Limited Health Check
Pomanda's financial health check has awarded Chempharm Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 5 areas for improvement. Company Health Check FAQs
2 Strong
4 Regular
5 Weak
Size
annual sales of £619.6k, make it smaller than the average company (£4.7m)
- Chempharm Limited
£4.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 2%, show it is growing at a slower rate (6.1%)
- Chempharm Limited
6.1% - Industry AVG
Production
with a gross margin of 35.9%, this company has a comparable cost of product (35.9%)
- Chempharm Limited
35.9% - Industry AVG
Profitability
an operating margin of 7.1% make it more profitable than the average company (4.7%)
- Chempharm Limited
4.7% - Industry AVG
Employees
with 8 employees, this is below the industry average (38)
8 - Chempharm Limited
38 - Industry AVG
Pay Structure
on an average salary of £26.1k, the company has an equivalent pay structure (£26.1k)
- Chempharm Limited
£26.1k - Industry AVG
Efficiency
resulting in sales per employee of £77.5k, this is equally as efficient (£88.1k)
- Chempharm Limited
£88.1k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Chempharm Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 135 days, this is slower than average (41 days)
- Chempharm Limited
41 days - Industry AVG
Stock Days
it holds stock equivalent to 27 days, this is in line with average (25 days)
- Chempharm Limited
25 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 9 weeks, this is less cash available to meet short term requirements (57 weeks)
9 weeks - Chempharm Limited
57 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 72%, this is a higher level of debt than the average (43.9%)
72% - Chempharm Limited
43.9% - Industry AVG
CHEMPHARM LIMITED financials
Chempharm Limited's latest turnover from September 2023 is estimated at £619.6 thousand and the company has net assets of £294.4 thousand. According to their latest financial statements, Chempharm Limited has 8 employees and maintains cash reserves of £57.7 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | Aug 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | |||||||||||||||
Tax | |||||||||||||||
Profit After Tax | |||||||||||||||
Dividends Paid | |||||||||||||||
Retained Profit | |||||||||||||||
Employee Costs | |||||||||||||||
Number Of Employees | 8 | 5 | 5 | 7 | 9 | 12 | |||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | Aug 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 58,428 | 31,883 | 39,852 | 49,685 | 44,988 | 1,560 | 1,950 | 2,438 | 3,047 | 3,324 | 2,852 | 730 | 859 | 1,011 | 1,190 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,800 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 58,428 | 31,883 | 39,852 | 49,685 | 44,988 | 1,560 | 1,950 | 2,438 | 3,047 | 3,324 | 2,852 | 730 | 859 | 1,011 | 3,990 |
Stock & work in progress | 29,945 | 27,480 | 23,394 | 52,645 | 52,148 | 24,902 | 0 | 20,151 | 15,171 | 23,525 | 24,325 | 22,804 | 21,749 | 19,699 | 15,696 |
Trade Debtors | 0 | 0 | 78,184 | 54,062 | 107,069 | 150,827 | 182,201 | 75,263 | 107,462 | 38,129 | 9,958 | 9,361 | 14,430 | 38,658 | 20,289 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 906,058 | 244,412 | 173,157 | 145,665 | 37,511 | 55,970 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 57,669 | 693,480 | 468,728 | 315,523 | 96,970 | 37,995 | 0 | 49,555 | 21,890 | 33,608 | 34,979 | 35,264 | 32,165 | 44 | 2,272 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 993,672 | 965,372 | 743,463 | 567,895 | 293,698 | 269,694 | 182,201 | 144,969 | 144,523 | 95,262 | 69,262 | 67,429 | 68,344 | 58,401 | 38,257 |
total assets | 1,052,100 | 997,255 | 783,315 | 617,580 | 338,686 | 271,254 | 184,151 | 147,407 | 147,570 | 98,586 | 72,114 | 68,159 | 69,203 | 59,412 | 42,247 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 10,000 | 10,000 | 10,000 | 2,500 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 147,457 | 123,770 | 131,103 | 112,145 | 97,201 | 60,836 | 63,289 | 61,397 | 94,549 | 72,392 | 53,063 | 49,447 | 51,955 | 50,458 | 32,793 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 6,342 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 173,912 | 207,869 | 186,139 | 153,768 | 71,714 | 14,312 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 331,369 | 341,639 | 327,242 | 268,413 | 168,915 | 81,490 | 63,289 | 61,397 | 94,549 | 72,392 | 53,063 | 49,447 | 51,955 | 50,458 | 32,793 |
loans | 422,743 | 372,068 | 283,368 | 209,690 | 29,156 | 18,169 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 3,615 | 2,787 | 3,524 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 426,358 | 374,855 | 286,892 | 209,690 | 29,156 | 18,169 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 757,727 | 716,494 | 614,134 | 478,103 | 198,071 | 99,659 | 63,289 | 61,397 | 94,549 | 72,392 | 53,063 | 49,447 | 51,955 | 50,458 | 32,793 |
net assets | 294,373 | 280,761 | 169,181 | 139,477 | 140,615 | 171,595 | 120,862 | 86,010 | 53,021 | 26,194 | 19,051 | 18,712 | 17,248 | 8,954 | 9,454 |
total shareholders funds | 294,373 | 280,761 | 169,181 | 139,477 | 140,615 | 171,595 | 120,862 | 86,010 | 53,021 | 26,194 | 19,051 | 18,712 | 17,248 | 8,954 | 9,454 |
Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | Aug 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | 14,607 | 7,969 | 9,963 | 12,421 | 9,051 | 0 | 609 | 277 | 831 | 712 | 129 | 152 | 179 | 210 | |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,800 | 2,800 | |
Tax | |||||||||||||||
Stock | 2,465 | 4,086 | -29,251 | 497 | 27,246 | 24,902 | -20,151 | 4,980 | -8,354 | -800 | 1,521 | 1,055 | 2,050 | 4,003 | 15,696 |
Debtors | 661,646 | -6,929 | 51,614 | 55,147 | -62,217 | 24,596 | 106,938 | -32,199 | 69,333 | 28,171 | 597 | -5,069 | -24,228 | 18,369 | 20,289 |
Creditors | 23,687 | -7,333 | 18,958 | 14,944 | 36,365 | -2,453 | 1,892 | -33,152 | 22,157 | 19,329 | 3,616 | -2,508 | 1,497 | 17,665 | 32,793 |
Accruals and Deferred Income | -33,957 | 21,730 | 32,371 | 82,054 | 57,402 | 14,312 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 828 | -737 | 3,524 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | 0 | 0 | 7,500 | 2,500 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | -6,342 | 6,342 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 50,675 | 88,700 | 73,678 | 180,534 | 10,987 | 18,169 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | |||||||||||||||
cash and cash equivalents | |||||||||||||||
cash | -635,811 | 224,752 | 153,205 | 218,553 | 58,975 | 37,995 | -49,555 | 27,665 | -11,718 | -1,371 | -285 | 3,099 | 32,121 | -2,228 | 2,272 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -635,811 | 224,752 | 153,205 | 218,553 | 58,975 | 37,995 | -49,555 | 27,665 | -11,718 | -1,371 | -285 | 3,099 | 32,121 | -2,228 | 2,272 |
chempharm limited Credit Report and Business Information
Chempharm Limited Competitor Analysis
Perform a competitor analysis for chempharm limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in B71 area or any other competitors across 12 key performance metrics.
chempharm limited Ownership
CHEMPHARM LIMITED group structure
Chempharm Limited has no subsidiary companies.
chempharm limited directors
Chempharm Limited currently has 4 directors. The longest serving directors include Mr Rajinder Sahota (Feb 2015) and Mrs Dalvinder Kaur (Feb 2015).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Rajinder Sahota | England | 47 years | Feb 2015 | - | Director |
Mrs Dalvinder Kaur | England | 71 years | Feb 2015 | - | Director |
Mr Gurmail Singh | England | 72 years | Feb 2015 | - | Director |
Mr Jeetender Sahota | England | 50 years | Aug 2024 | - | Director |
P&L
September 2023turnover
619.6k
+40%
operating profit
44.2k
0%
gross margin
36%
-1.7%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2023net assets
294.4k
+0.05%
total assets
1.1m
+0.05%
cash
57.7k
-0.92%
net assets
Total assets minus all liabilities
chempharm limited company details
company number
02884816
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
96090 - Other personal service activities n.e.c.
86900 - Other human health activities
incorporation date
January 1994
age
30
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
September 2023
previous names
N/A
accountant
-
auditor
-
address
85 church vale, west bromwich, B71 4DH
Bank
NATIONAL WESTMINSTER BANK PLC, NATIONAL WESTMINSTER BANK PLC
Legal Advisor
-
chempharm limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to chempharm limited.
chempharm limited Companies House Filings - See Documents
date | description | view/download |
---|